Schedule 13G ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K309

Event date: 2024-03-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-024390
Form type
SC 13G
Filer
Regulus Therapeutics Inc.
CIK
CIK 1505512
Filed
Mar 20, 2024
Reporting period
Mar 14, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub